Vital Biosciences

Vital Biosciences

About Vital Biosciences

Simplify's Rating
Why Vital Biosciences is rated
C
Rated D+ on Competitive Edge
Rated B on Growth Potential
Rated C on Rating Differentiation

Industries

Biotechnology

Healthcare

Company Size

51-200

Company Stage

Seed

Total Funding

$46.7M

Headquarters

Mississauga, Canada

Founded

2018

Overview

📈
Significant Headcount Growth
Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for at-home diagnostics boosts Vital's market potential.
  • AI integration offers Vital a competitive edge in diagnostic accuracy.
  • Global blood testing market growth aligns with Vital's technological advancements.

What critics are saying

  • Increased competition from established companies like Abbott and Roche.
  • Potential regulatory scrutiny due to past industry scandals.
  • Public skepticism may hinder market adoption of new diagnostics.

What makes Vital Biosciences unique

  • Vital Biosciences focuses on accessible, rapid blood diagnostics post-Theranos era.
  • The company integrates AI to enhance diagnostic accuracy and speed.
  • Vital collaborates with tech giants for cloud-based data management in diagnostics.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$46.7M

Above

Industry Average

Funded Over

1 Rounds

Early VC funding comparison data is currently unavailable. We're working to provide this information soon!
Early VC Funding Comparison
Coming Soon

Benefits

Competitive compensation and benefits package

Professional Development Budget

Conference Attendance Budget

Growth & Insights and Company News

Headcount

6 month growth

↑ 6%

1 year growth

↑ 6%

2 year growth

↑ 5%
Longevity Technology
Jul 27th, 2023
Vital Biosciences raises $48m for revolutionary blood diagnostic tech

Backers include Sam Altman and Marc Benioff as company seeks to create accessible diagnostics and expedite clinical interventions.

BetaKit
Jul 26th, 2023
Vital Biosciences reveals blood-testing solution

After the bloody mess at Theranos, Vital is among the new wave of startups developing accessible diagnostics.

Bloomberg
Jul 24th, 2023
Sam Altman, Valley VCs Bet $48 Million on Blood-Testing Startup

Years after Theranos, Vital Biosciences wants to prove Silicon Valley really can disrupt blood testing.

Recently Posted Jobs

Sign up to get curated job recommendations

Vital Biosciences is Hiring for 0 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Vital Biosciences's jobs every 8 hours, so check again soon! Browse all jobs →